Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Annaleah Larson"'
Autor:
Siwen Hu-Lieskovan, Ngan Nguyen, Magdalena Kovacsovics-Bankowski, John Hyngstrom, Li-Chun Cheng, Jordan P McPherson, Umang Swami, Matthew H Spitzer, Johanna M Sweere, Connor P Healy, Natalia Sigal, William D Chronister, Shane A Evans, John Marsiglio, Berit Gibson, Alyssa Erickson-Wayman, Yoko S Derose, Annaleah Larson Eliason, Carlos O Medina, Ramji Srinivasan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Immune-related adverse events (irAEs) are major barriers of clinical management and further development of immune checkpoint inhibitors (ICIs) for cancer therapy. Therefore, biomarkers associated with the onset of severe irAEs are needed.
Externí odkaz:
https://doaj.org/article/33adf4f87d5845b590a6128eac8e0678
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Connor Healy, Magdalena Kovacsovics, Natalia Sigal, Li-Chun Cheng, Shane Evans, John Marsiglio, Berit Gibson, Yoko DeRose, Annaleah Larson, Carlos Medina, Jolien Sweere, Ramji Srinivasan, Matthew Spitzer, John Hyngstrom, Siwen Hu-Lieskovan
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Muhammad Zaki Fadlullah Wilmot, Magdalena Kovacsovics, Xuechen Wang, Samuel Coleman, John Marsiglio, Berit Gibson, Yoko DeRose, Qin Zhou, Annaleah Larson, John Hyngstrom, Ben Haaland, Siwen Hu-Lieskovan, Aik Choon Tan
Publikováno v:
Cancer Research. 83:2144-2144
Advances in immunotherapy including immune checkpoint inhibitors (ICIs) have transformed the standard of care of many cancers including melanoma. However, the benefit of ICIs is hampered by immune related adverse events (irAEs). The frequency of irAE